Navigation Links
University of Denver bullying victimization study
Date:2/22/2008

DENVER-A University of Denver study shows a curriculum-based bullying prevention program reduced incidents of bullying by 20 percent, twice as much as in the study control group.

Jeffrey M. Jenson and William A. Dieterich of the University of Denvers Graduate School of Social Work studied more than 1,100 students in 28 elementary schools in Denver public schools. One group was exposed to a bullying prevention program called Youth Matters (YM). A second control group of students was not.

Self-reported bully victimization among students taking the Youth Matters curriculum decreased at 20 percent compared to a 10 percent drop from students in the control group.

By the end of the study bully victimization was significantly lower in the YM group relative to the control group, Jenson reports. This outcome is encouraging because the curriculum modules tested in the study focused on teaching the social and emotional skills necessary to avoid becoming a bully victim.

The results are detailed in a paper, Effects of a Skills-based Prevention Program on Bullying and Bully Victimization among Elementary School Children, published in the December 2007 issue of Prevention Science by the Society for Prevention Research.

Previous research has shown that about 25 percent of elementary students either bully or are victims of bullying. Studies also suggest that both bullies and victims are at risk for later mental health problems and involvement in anti-social activities. Educators have focused attention on bullying in the wake of school shootings over the last decade. In some of those cases there were indications that the shooters had themselves been bullied as young children.

Students in the Jenson-Dieterich study who participated in the Youth Matters curriculum received training in four 10-week modules over the course of two academic years. The curriculum focused on two themes: issues and skills related to bullyi
'/>"/>

Contact: Dave Brendsel
dbrendse@du.edu
303-871-2775
University of Denver
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. The Northern Illinois University Murders Due to Chemical Imbalances or Chemical Balancers - Drugs? - Fred A. Baughman Jr., MD, Neurologist/Child Neurologist
2. Researcher of the University of Navarra discovered potential antidepressant compounds
3. ADAMS Performs Management Services for University Hospitals $600 Million Expansion/Renovation Program in Cleveland, OH
4. Cell phone-cancer link found by Tel Aviv University scientist
5. The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology
6. Vanderbilt University Medical Center and Waters Collaborate on Tissue Imaging Research Using SYNAPT HDMS
7. Good Neighbor Pharmacy(R) Makes Major Gift for Endowed Chair in Community Pharmacy at University of the Pacific
8. Elderly more likely to deny smoking when asked, says Case Western Reserve University researcher
9. Aegis Therapies and Rocky Mountain University of Health Professions Announce Scholarship Recipients
10. Parents Identify Health Topics They Want Doctors to Discuss with Kids - New Research for University of Michigan Conducted by Knowledge Networks
11. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)... Fans Can ,Start Their Engines, and Nominate Now a...TSBURGH, July 9 /PRNewswire/ -- TUMS, one of the m...elief, is launching a nationwide search for,one lu...QuikPak 500 Sprint,Cup Series race at Martinsville...., (Photo: http://www.newscom.com/cgi-bin/prnh/2...
(Date:7/9/2008)...o be heavier if they spend a lot of time on the In...uly 9 (HealthDay News) -- Teen girls who spend a ... their weight creeping slowly up than adolescents ...n, new research shows. , And the association be...the researchers accounted for the amount of exerci...
(Date:7/9/2008)... global needs for the increasingly complex healthc... YORK, July 9 /PRNewswire/ -- Cohn & Wolfe has ann...ealthcare public relations firm,specializing in a... which,will be led by Jill Dosik as president, off... marketing strategy and leading-edge digital healt...
(Date:7/9/2008)...and, July 9 /Xinhua-PRNewswire/ -- Chindex,Interna...ican provider of,international healthcare services...epublic of China, today announced that its Healthc...ncommercial China travel health,information websit...p://www.ChinaHealthWatch.org ) is a,comprehensive...
Breaking Medicine News(10 mins):Health News:TUMS Announces Nationwide Search for Grand Marshal at TUMS QuikPak 500 2Health News:Surfing to a Higher Weight 2Health News:Surfing to a Higher Weight 3Health News:Cohn & Wolfe Launches GCI Health, One of the World's Largest Healthcare Public Relations Firms 2Health News:Chindex's United Family Healthcare Launches ChinaHealthWatch.org - A global resource for travelers to China 2
...w technique for checking the spread of cancer of t...se. Cancer of the oesophagus - the tube leading fr... a year in the UK, making it the eighth most commo...r through the lymph glands. But it is hard for doc...
...ntists warn that, too much sleep and snoring could...researchers from the University of Buffalo, New Yo... a night, snoring or being drowsy during the day c...s means snoring and sleep disorders will now have ...
...new genes which are active in prostate cancer have... level, cancer tissue differs markedly from normal...esearchers have now developed the tools that can v...hat characterise the cancerous cell. Using microar...
...ican doctors are using a computer to do a double c...gular mammogram tests to check for early breast ca.... Researchers at the Sloan-Kettering Cancer Resear... detection (CAD) to help analyse lesions that a fi...
Other Medicine News:
(Date:7/9/2008)... Research Has Set National Safety Standards, B...wire-USNewswire/ -- In a congressional,hearing Sec...iscussed the,safety and importance of the research...ffairs (VA) as well as an absolute commitment to i...ingle veteran would feel improperly,treated or mis...
(Date:7/9/2008)... SAN DIEGO, July 9 /- A...announced positive results from a multiple-ascendi...ate the compound,s safety,pharmacokinetics and ph...vered oral drug candidate intended for the treatme...ions., The Phase 1b trial was a randomized, doubl...
(Date:7/8/2008)... MAIDENHEAD, England, July 8 /PRNewswire-First...dren Against the Leading,Vaccine-Preventable Cause...ountries of Cyprus, Hungary, the Kingdom of,Bahrai... for announcing,their decisions to routinely immun...l disease by adding PREVENAR(TM) PCV7 (Pneumococca...
(Date:7/8/2008)... GLP-1 Has Potential to Treat Type 2 Diabetes Us... Technology, CEDAR KNOLLS, N.J., July 8 /PRN... (Nasdaq: EMIS ) today announced findings from a ...1 peptide safely and effectively.,The study used a...ligen(R),technology, and was conducted at Universi...
Breaking Medicine Technology:Secretary Reinforces VA's Commitment to Research Safety and Veteran Focus 2Secretary Reinforces VA's Commitment to Research Safety and Veteran Focus 3Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 2Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 3Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 4Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis 5Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules 2Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules 3Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations 2Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations 3BioSpace and the Massachusetts Biotechnology Council Launch 2008 Genetown 28TM 29 Hotbed Campaign 2545 1BioSpace and the Massachusetts Biotechnology Council Launch 2008 Genetown 28TM 29 Hotbed Campaign 2545 2Transgenes Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non Small Cell Lung Cancer 2541 1Transgenes Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non Small Cell Lung Cancer 2541 2Transgenes Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non Small Cell Lung Cancer 2541 3Biofuels Sustainability 1842 1Biofuels Sustainability 1842 2Biofuels Sustainability 1842 3Protein in human hair shows promise for regenerating nerves 9372 1Protein in human hair shows promise for regenerating nerves 9372 2Protein in human hair shows promise for regenerating nerves 9372 3
... Switzerland, April 3, 2007 (PRIME NEWSWIRE) -- Ne...ogical and,pharmacokinetic profiles of Basilea,s (...ole and isavuconazole. Studies reported,both for c...phalosporin in late-stage development, and for isa...asive fungal infections,yielded further data on t...
...France, April 04, 2007 /PRNewswire/ -- Novagali Ph...y specialized in,ophthalmology, announces today po...f Vekacia(R) in children suffering from Vernal,Ker...t was shown,that both symptoms and signs of diseas...ermore, the tolerability to Vekacia(R),was excelle...
Other Medicine Technology:Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 2Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 3Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 4Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 5Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 6Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 7Novagali Pharma Announces Positive Vekacia Clinical Results From,Pivotal Phase III Trial in Vernal Keratoconjunctivitis 2
Rapid reagent impregnated disk test for presumptive identification of Candida albicans.
...sive Electronic Medical Records for small and larg...tient flow from check-in to check-out. Review the ...rent medications, to allergies, labs and charts al...ecords immediately. Communicate electronically wit...
Written specifically for urologists by a urologist, this EMR software utilizes touch screen technology to streamline your workflow and virtually eliminate the use of a cumbersome mouse. Its intuitive
...t Record is a new generation of advanced Electroni...the largest, numerically codified medical vocabula... data elements embedded in MedcomSoft Record, heal... an easy and intuitive point and click system and ...
Medicine Products: